Improving The Principles Of Treatment In Patients With Zoonotic Leishmaniasis With The Immunomodulator Gepon And Methylene Blue Using The Alt Vostok Apparatus
Abstract
The object of the study was 102 patients with zoonotic leishmaniasis aged 2 to 65 years. The diagnosis of zoonotic leishmaniasis was established by clinical and epidemiological data and confirmed by the results of parasitological studies.
We studied the duration of the clinical periods of zoonotic leishmaniasis against the background of complex therapy with methylene blue using the ALT Vostok apparatus in the control group of 51 patients and complex therapy with methylene blue using the ALT Vostok apparatus and the immunomodulator Gepon in the main group of 51 patients. The results of the study showed that in patients of the main group, on the background of treatment with the ALT Vostok apparatus using the immunomodulator Gepon, the duration of the main periods was significantly reduced than in the control group, who were treated only with methylene blue using the ALT Vostok model-03 apparatus.
Keywords
Downloads
References
- Weekly epidemiological record of WHO 2018.
- Dzhalilova N.A., 2014.
- Dudchenko M.I. et al., 2002.
- HIV peptides.1998. Rupert, H.
- Silin D.S., Lyubomskaya O.V., Ershov, F.I., Frolov V.M., Kutsyna, 2009.
- Khaitov R.M., Pinegin B.V., 2001.
- Ataullakhanov R.I., Holmes R.D., Narovlyansky A.N. et al., 2002.